Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |